glp-1/gip treatment Understand Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy Targeting GLP-1, GIP & GCG

The least-squares mean percentage change in body weight at 24 weeks in the retatrutide groups was 7.2% in the 1 mg group, and up to 17.5% in the 12 mg group, as compared with 1.6% in the placebo group

You decide if and when you want to move forward

We provide the full spectrum of care-from initial medical assessment and lab review to prescription management and ongoing virtual follow-ups-all through a secure online platform

How GIP Medications Support Weight Loss Mechanism of Action of GIP Medications GIP medications, relatively newer in the weight loss pharmacotherapy landscape, work by mimicking the action of the GIP hormone

Theres a lot of misinformation, a lot of false science out there when it comes to eating and eating disorders